Skip to main content
Fig. 4 | BMC Genomic Data

Fig. 4

From: Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker

Fig. 4

Correlation analysis of CARM1 gene expression with different pathological stages and survival prognosis across cancers in TCGA. a Based on data from TCGA, CARM1 gene expression levels were analyzed according to the main pathological stages. Log2 (TPM + 1) was applied for log-scale. GEPIA2 tool was used to perform overall survival (b) and disease-free survival (c) analysis of cancers in TCGA according to CARM1 gene expression. The survival map and Kaplan-Meier curve of positive results are given

Back to article page

BMC Genomic Data

ISSN: 2730-6844

Contact us